| Schedule of profit or loss and total assets for each reportable segment |
Six Months Ended February 29, 2024 |
|
IP
Licensing
|
|
|
B2B
Product
|
|
|
R&D |
|
|
Corporate |
|
|
Consolidated
Total
|
|
Revenue |
|
$ |
289,990 |
|
|
$ |
5,388 |
|
|
$ |
900 |
|
|
$ |
- |
|
|
$ |
296,278 |
|
Cost of goods sold |
|
$ |
- |
|
|
$ |
(4,822 |
) |
|
$ |
- |
|
|
$ |
- |
|
|
$ |
(4,822 |
) |
Operating expenses |
|
$ |
(345 |
) |
|
$ |
(1,354 |
) |
|
$ |
(820,270 |
) |
|
$ |
(1,400,223 |
) |
|
$ |
(2,222,192 |
) |
Other Income(Expense) |
|
$ |
|
|
|
$ |
- |
|
|
$ |
- |
|
|
$ |
(30,624 |
) |
|
$ |
(30,624 |
) |
Segment loss |
|
$ |
289,645 |
|
|
$ |
(788 |
) |
|
$ |
(819,370 |
) |
|
$ |
(1,430,847 |
) |
|
$ |
(1,961,360 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets |
|
$ |
98,877 |
|
|
$ |
63,573 |
|
|
$ |
491,551 |
|
|
$ |
5,698,042 |
|
|
$ |
6,352,043 |
|
Six Months Ended February 28, 2023 |
|
IP
Licensing
|
|
|
B2B
Product
|
|
|
R&D |
|
|
Corporate |
|
|
Consolidated
Total
|
|
Revenue |
|
$ |
80,310 |
|
|
$ |
30,300 |
|
|
$ |
7,150 |
|
|
$ |
- |
|
|
$ |
117,760 |
|
Cost of goods sold |
|
$ |
- |
|
|
$ |
(18,753 |
) |
|
$ |
- |
|
|
$ |
- |
|
|
$ |
(18,753 |
) |
Operating expenses |
|
$ |
(45,758 |
) |
|
$ |
(183,030 |
) |
|
$ |
(1,525,667 |
) |
|
$ |
(1,363,596 |
) |
|
$ |
(3,118,051 |
) |
Other Income(Expense) |
|
$ |
|
|
|
$ |
- |
|
|
$ |
- |
|
|
$ |
(60,900 |
) |
|
$ |
(60,900 |
) |
Segment loss |
|
$ |
34,552 |
|
|
$ |
(171,483 |
) |
|
$ |
(1,518,517 |
) |
|
$ |
(1,424,496 |
) |
|
$ |
(3,079,944 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets |
|
$ |
114,546 |
|
|
$ |
72,929 |
|
|
$ |
1,518,517 |
|
|
$ |
3,148,987 |
|
|
$ |
4,854,979 |
|
|